Two out of three people with the neurodegenerative condition experienced delirium in hospital
News
Strand Therapeutics develops new class of mRNA molecules for cancer
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
University of Liverpool to lead £125m research facility supported by UKRI investment
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m
PMLiVE’s T40 – open for submissions!
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy
The progressive and incurable brain disorder currently affects approximately 100 patients worldwide
PhaSER Biomedical and the Sanders TDI partner for clinical drug discovery research
PhaSER will provide 8HUM mouse models for the TDI to accelerate a pipeline of novel therapeutic targets
Researchers identify group of biological markers found in high levels in TB patients
According to the World Health Organization, TB is responsible for over one million annual deaths
Inizio Engage and Applied Driving partner to support clinical workers with safety app
The Companion+ Mobile Safety App will be rolled out to a further 115 users within the UK and US
Francis Crick researchers target cancer cells’ ability to survive at low oxygen levels
LDHA and GOT1 enzymes successfully targeted and halted energy production in hard-to-reach cancer cells
Skin biopsy test detects abnormalities of key biomarker in neurodegenerative disorders
Estimated to affect 2.5 million people in the US, synucleinopathies comprise four neurodegenerative disorders
Four international teams awarded £4.7m to investigate heart and circulatory diseases
These types of conditions are responsible for 25% of all UK deaths and affect 7.6 million people nationally
Innovate UK awards ten projects over £6m to develop new clinical tools for dementia
Dementia is estimated to affect 850,000 people in the UK and costs the nation around £23bn a year
Researchers reveal protein found in human sweat could protect against Lyme disease
The bacterial infection transmitted by ticks affects nearly half a million people in the US every year
Parkinson’s UK grants funding of up to nearly £450,000 to four new research projects
The globally fast-growing progressive neurological condition affects around 153,000 people in the UK
New study reveals neurological conditions as leading cause of ill health worldwide
In 2021, neurological conditions, including Alzheimer’s disease, affected approximately 3.4 billion people globally
